Altis Biosystems

Durham, NC · Founded 2015 · Privately Held (backing)

Developer of a stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research. Altis Biosystems is based in Durham, NC and was founded in 2015. It was valued at $20 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $8.8 million across 3 recorded rounds; the latest was a $2.1 million seed round in Mar 2025.

PMV mark · valuation
$20.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$8.8M
Last round
Seed Round
Mar 2025
What is Altis Biosystems worth?
$20.0MPrivateMarketView mark · Oct 2026

Valued at $20.0M at its later-stage round, Apr 2025. Nothing has traded since.

Free account
More of Altis Biosystems with a free account
  • ·The complete investor list: 22 names
  • ·Watch Altis Biosystems: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Altis Biosystems funding history

3 rounds
DateRoundRaisedPost-money
Mar 2025Seed Round$2.1M▮
Jul 2022Seed Round$1.4M▮
Dec 2019Seed Round$3.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Altis Biosystems valuation

Altis Biosystems was valued at $20 million at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Altis Biosystems raised?

Altis Biosystems has raised $8.8 million across 3 recorded rounds since 2019. The largest was a $3.1 million seed round in Dec 2019; the most recent was a $2.1 million seed round in Mar 2025.

Altis Biosystems has filed 4 Form Ds with the SEC since 2020, most recently in Apr 2025 ($2.1 million sold to 9 investors).

How Altis Biosystems's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Altis Biosystems, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Altis Biosystems

What is Altis Biosystems worth?
Altis Biosystems is valued at $20.0M as of Oct 2026. Valued at $20.0M at its later-stage round, Apr 2025. Nothing has traded since.
How much has Altis Biosystems raised?
Altis Biosystems has raised $8.8M in total funding across 3 recorded rounds.
When did Altis Biosystems last raise?
Altis Biosystems last raised in Mar 2025 (Seed Round), raising $2.1M.